Reaktionsgleichung
[NH2:1][C:2]1[NH:3][C:4](=O)[C:5]2[N:10]=[C:9]([CH2:11][CH2:12][C:13]3[CH:18]=[CH:17][C:16]([F:19])=[CH:15][CH:14]=3)[S:8][C:6]=2[N:7]=1.C1CCN2C(=NCCC2)CC1.F[P-](F)(F)(F)(F)F.N1(O[P+](N(C)C)(N(C)C)N(C)C)C2C=CC=CC=2N=N1.[O:59]([CH2:66][CH2:67][N:68]1[CH2:73][CH2:72][NH:71][CH2:70][CH2:69]1)[C:60]1[CH:65]=[CH:64][CH:63]=[CH:62][CH:61]=1>CN(C=O)C>[NH2:1][C:2]1[N:3]=[C:4]([N:71]2[CH2:70][CH2:69][N:68]([CH2:67][CH2:66][O:59][C:60]3[CH:65]=[CH:64][CH:63]=[CH:62][CH:61]=3)[CH2:73][CH2:72]2)[C:5]2[N:10]=[C:9]([CH2:11][CH2:12][C:13]3[CH:18]=[CH:17][C:16]([F:19])=[CH:15][CH:14]=3)[S:8][C:6]=2[N:7]=1Komponenten
6
Edukt 4
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
To a solution of 5-amino-2-[2-(4-fluorophenyl)ethyl]-6H-thiazolo[5,4-d]pyrimidin-7-one (133 mg, 0.46 mmol) in DMF (5 ml) was added DBU (0.69 mmol), BOP (0.59 mmol) and 1-(2-phenoxyethyl)piperazine (1.37 mmol). The reaction mixture was stirred at room temperature for 3 hours whereupon the solvent was removed in vacuo. The resulting residue was purified by flash chromatography on silica, the mobile phase being a mixture of methanol and dichloromethane (in a ratio gradually ranging from 100% CH2Cl2 to 2% CH3OH in CH2Cl2), yielding the pure title compound (56 mg) which was characterized by its mass spectrum: MS m/z (%): 479 ([M+H]+, 100).
Aufarbeitung
- customwas removed in vacuo
- customThe resulting residue was purified by flash chromatography on silica
- additiona mixture of methanol and dichloromethane (in a ratio
Quellen und Nachweise
- ORD-Eintrag
- ord-7ccefc40a3bb4ce0a341bfb645c5cc1e
- Quelldatensatz
- uspto-grants-2015_11
- Patentnummer
- US09193741B2
Verknüpfte Notizen
Wird geladen…